Artia Global Partners’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-102,900
Closed -$2.32M 36
2024
Q4
$2.32M Buy
+102,900
New +$2.32M 0.83% 20